Display options
Share it on

Mol Cell Biol. 2011 Jan;31(2):267-76. doi: 10.1128/MCB.01058-10. Epub 2010 Nov 22.

The essential function for serum response factor in T-cell development reflects its specific coupling to extracellular signal-regulated kinase signaling.

Molecular and cellular biology

Anastasia Mylona, Robert Nicolas, Diane Maurice, Mathew Sargent, David Tuil, Dominique Daegelen, Richard Treisman, Patrick Costello

Affiliations

  1. Transcription Laboratory, Cancer Research UK London Research Institute, Lincoln's Inn Fields Laboratories, 44 Lincoln's Inn Fields, London WC2A 3LY, United Kingdom.

PMID: 21098124 PMCID: PMC3019971 DOI: 10.1128/MCB.01058-10

Abstract

Serum response factor (SRF) recruits members of two families of signal-regulated coactivators, the extracellular signal-regulated kinase (ERK)-regulated ternary complex factors (TCFs) and the actin-regulated myocardin-related transcription factors (MRTFs), to its target genes through its DNA-binding domain. Whether coactivator association is required for SRF function in vivo and whether particular SRF functions reflect specific coupling to one or the other signal pathway have remained largely unexplored. We show that SRF is essential for thymocyte positive selection and thymic T(reg) and NK T-cell development but dispensable for early thymocyte development and negative selection. Expression of wild-type SRF, or mutants lacking the N-terminal phosphorylation sites or C-terminal transcriptional activation domain, restores positive selection in SRF null thymocytes. In contrast, SRF.V194E, which cannot recruit TCF or MRTF family members, is inactive, although it is recruited to target genes. Fusion of a TCF C-terminal activation domain to SRF.V194E effectively restores ERK-dependent single-positive (SP) thymocyte development. The resulting SP thymocytes exhibit normal surface marker expression and proliferation following T-cell receptor cross-linking. Thus, ERK signaling through the TCF pathway to SRF is necessary and sufficient for SRF function in thymocyte positive selection.

References

  1. J Neurosci. 2009 Apr 8;29(14):4512-8 - PubMed
  2. Eur J Immunol. 2003 Feb;33(2):314-25 - PubMed
  3. J Immunol. 2008 Dec 1;181(11):7778-85 - PubMed
  4. J Exp Med. 2004 Nov 15;200(10):1221-30 - PubMed
  5. Nat Cell Biol. 2009 Mar;11(3):257-68 - PubMed
  6. J Immunol. 2010 Jul 15;185(2):1082-92 - PubMed
  7. Cell. 2003 May 2;113(3):329-42 - PubMed
  8. EMBO J. 1992 Jan;11(1):97-105 - PubMed
  9. Cell. 1993 Apr 23;73(2):395-406 - PubMed
  10. Nature. 1989 Jul 6;340(6228):68-70 - PubMed
  11. Mol Cell Biol. 1993 Oct;13(10):6260-73 - PubMed
  12. Immunity. 2009 Oct 16;31(4):565-75 - PubMed
  13. J Biol Chem. 2001 Jul 6;276(27):24531-9 - PubMed
  14. Development. 2010 Jul;137(14):2365-74 - PubMed
  15. Nucleic Acids Res. 2009 Dec;37(22):7368-80 - PubMed
  16. Science. 1999 Oct 22;286(5440):790-3 - PubMed
  17. Genes Dev. 2006 Jun 15;20(12):1545-56 - PubMed
  18. Nature. 1988 Jun 23;333(6175):742-6 - PubMed
  19. EMBO J. 1992 Mar;11(3):1045-54 - PubMed
  20. Immunol Cell Biol. 1998 Feb;76(1):34-40 - PubMed
  21. Dev Immunol. 1993;3(3):159-74 - PubMed
  22. J Exp Med. 1997 Sep 15;186(6):877-85 - PubMed
  23. Immunity. 2005 Oct;23(4):431-43 - PubMed
  24. Nat Immunol. 2010 Aug;11(8):666-73 - PubMed
  25. Nature. 2004 Mar 11;428(6979):185-9 - PubMed
  26. Gene. 2004 Jan 7;324:1-14 - PubMed
  27. Nature. 2007 Nov 29;450(7170):731-5 - PubMed
  28. Eur J Immunol. 2010 Jan;40(1):232-41 - PubMed
  29. Nat Immunol. 2004 Mar;5(3):289-98 - PubMed
  30. Mol Cell Biol. 1993 Aug;13(8):4640-7 - PubMed
  31. J Immunol. 2002 Feb 15;168(4):1649-58 - PubMed
  32. J Biol Chem. 2000 Jul 21;275(29):22563-7 - PubMed
  33. Genome Res. 2006 Feb;16(2):197-207 - PubMed
  34. Immunity. 2000 Jul;13(1):85-94 - PubMed
  35. Nat Rev Mol Cell Biol. 2010 May;11(5):353-65 - PubMed
  36. J Immunol. 2007 Nov 15;179(10):6836-44 - PubMed
  37. Mol Cell Biol. 2004 Jun;24(12):5281-9 - PubMed
  38. PLoS Genet. 2007 Nov;3(11):e208 - PubMed
  39. Proc Natl Acad Sci U S A. 1992 Oct 15;89(20):9814-8 - PubMed
  40. J Biol Chem. 1998 Apr 24;273(17):10506-14 - PubMed
  41. Nat Rev Immunol. 2009 Feb;9(2):106-15 - PubMed
  42. J Exp Med. 2001 Aug 20;194(4):427-38 - PubMed
  43. Genes Dev. 2007 Aug 1;21(15):1882-94 - PubMed
  44. Nucleic Acids Res. 1996 Apr 1;24(7):1345-51 - PubMed
  45. Trends Cell Biol. 2006 Nov;16(11):588-96 - PubMed
  46. EMBO J. 1994 Nov 15;13(22):5421-32 - PubMed
  47. Proc Natl Acad Sci U S A. 2008 Nov 18;105(46):17824-9 - PubMed
  48. EMBO J. 1998 Nov 2;17(21):6289-99 - PubMed
  49. Genes Dev. 1990 Jun;4(6):955-67 - PubMed
  50. Mol Cell Biol. 2002 Oct;22(20):7083-92 - PubMed
  51. Nature. 2006 Dec 21;444(7122):1073-7 - PubMed
  52. Nat Neurosci. 2006 Feb;9(2):195-204 - PubMed
  53. Curr Opin Genet Dev. 1994 Feb;4(1):96-101 - PubMed
  54. Proc Natl Acad Sci U S A. 2005 Apr 26;102(17):6148-53 - PubMed
  55. J Immunol. 2002 Aug 15;169(4):1713-20 - PubMed
  56. Trends Biochem Sci. 2002 Jan;27(1):40-7 - PubMed
  57. J Biol Chem. 2007 Aug 17;282(33):24320-8 - PubMed
  58. J Cell Biol. 2002 Feb 18;156(4):737-50 - PubMed
  59. Mol Cell Biol. 2006 Jun;26(11):4134-48 - PubMed

Substances

MeSH terms

Publication Types

Grant support